canagliflozin vs phenytoin
Side-by-side comparison of canagliflozin and phenytoin. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
moderate Known Drug Interaction
Examples: Rifampin, phenytoin, phenobarbital, ritonavir Insulin or Insulin Secretagogues Clinical Impact: The risk of hypoglycemia is increased when INVOKANA is used concomitantly with insulin secretagogues (e.g., sulfonylurea) or insulin.
Recommendation: Your doctor may need to monitor your blood sugar more closely or adjust your dose of canagliflozin.
Invokana
Dilantin
Invokana is a medicine used with diet and exercise to lower blood sugar in adults with type 2 diabetes. It can also help reduce the risk of heart problems and kidney disease in some patients.
Phenytoin injection is used to treat certain types of seizures. It can also prevent seizures during or after neurosurgery.
Invokana is used to help control blood sugar levels in adults with type 2 diabetes. It is used along with diet and exercise. Invokana can also lower the risk of major heart problems like heart attack and stroke in adults with both type 2 diabetes and heart disease. It can also reduce the risk of kidney failure, heart-related death, and hospitalization for heart failure in adults with type 2 diabetes and kidney problems.
This medicine treats generalized tonic-clonic status epilepticus, a type of prolonged seizure. It also helps prevent and treat seizures that may happen during or after brain surgery. Sometimes, it can be used for a short time instead of the oral form of phenytoin when you cannot take the medicine by mouth.
Invokana is a type of medicine called an SGLT2 inhibitor. It works by preventing your kidneys from reabsorbing sugar back into your blood. This causes extra sugar to leave your body through your urine, which lowers your blood sugar levels.
Phenytoin works by slowing down the signals in the brain that cause seizures. It stabilizes nerve cell membranes, reducing excessive electrical activity. This helps to prevent seizures from starting or spreading.
- • Yeast infections of the vagina
- • Urinary tract infection
- • Increased urination
No common side effects listed.
- Diabetic ketoacidosis (high levels of ketones in the blood) 3,421
- Toe amputation 2,195
- Bone infection 2,163
- Sudden kidney damage 1,990
- Fungal infection 1,446
- The medicine is reacting with another medicine 1,547
- Seizure 1,382
- Poisoning from different substances 1,353
- Convulsion 1,260
- Prolonged seizure 790
Invokana can cause serious side effects, including: - Diabetic ketoacidosis (DKA): This is a serious condition where your body produces high levels of blood acids called ketones. DKA can be life-threatening. - Lower limb amputation: Invokana may increase your risk of needing an amputation of your foot or leg. - Volume depletion: Invokana can cause dehydration, which can lead to kidney problems and low blood pressure. - Serious infections: Invokana can increase your risk of urinary tract infections and a rare but serious infection of the tissue under the skin in the area between and around the anus and genitals (Fournier's gangrene).
This medicine can cause serious heart problems if given too quickly. The injection rate should not be faster than 50 mg per minute for adults, and 1 to 3 mg/kg/min (or 50 mg per minute, whichever is slower) for children. Your heart will be monitored closely during and after the injection.
Invokana is not recommended during the second and third trimesters of pregnancy because it may harm the developing baby's kidneys. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not recommended to use Invokana while breastfeeding.
Taking phenytoin during pregnancy may increase the risk of birth defects. If you are pregnant or plan to become pregnant, talk to your doctor about the risks and benefits of this medicine.
Also Compare, Nearby Drugs
Compare canagliflozin with
How to Read This canagliflozin vs phenytoin Comparison
canagliflozin is classified in the SGLT2 Inhibitor drug class, while phenytoin sits within the Anticonvulsant (Hydantoin) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, canagliflozin has 11,215 submissions while phenytoin has 6,332. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known moderate interaction flagged in FDA labeling, attributed to phenytoin can cause your body to process canagliflozin more quickly, which may lower the amount of medicine in your system.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between canagliflozin and phenytoin - always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.